Roche vet James Sabry departs—Chutes & Ladders fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.
The combination of bispecific antibody CTX-009 and chemotherapy received Fast Track Designation for advanced, previously treated biliary tract cancers.
By Dean Seal Compass Therapeutics said regulators have granted fast-track designation to its CTX-009 antibody in combination with paclitaxel for the treatment of biliary tract cancer. The.